FDA Grants First Priority Review Vouchers to Nine Drugs
TL;DR Summary
The FDA announced the first nine recipients of the Commissioner’s National Priority Review vouchers, which expedite drug reviews for products aligned with national health priorities. Notably, EMD Serono received a voucher after agreeing to lower prices for its fertility drugs, including Pergoveris, in a move highlighted by President Trump. The program aims to incentivize companies to develop and provide access to important medications.
Topics:business#drug-approval#emd-serono#fda#health#pharmaceutical-industry#priority-review-vouchers
- FDA announces first nine recipients of priority drug review vouchers statnews.com
- FDA unveils drugs to receive expedited review in support of ‘national priorities’ AP News
- US FDA announces recipients of national priority vouchers Reuters
- FDA Announces Fast-Track Reviews for Nine Drugs in New Program Bloomberg.com
- FDA names 9 first recipients of 1- to 2-month priority review vouchers Fierce Biotech
Reading Insights
Total Reads
0
Unique Readers
8
Time Saved
0 min
vs 1 min read
Condensed
60%
158 → 63 words
Want the full story? Read the original article
Read on statnews.com